The Interprofessional Medication Assessment for Older Patients
- Conditions
- MultimorbidityPolypharmacy
- Registration Number
- NCT02398812
- Lead Sponsor
- East Savo Hospital District
- Brief Summary
The objective of this pragmatic multi-center randomized controlled trial is to test the effectiveness of interprofessional medication assessment in older patients needing home care due to their diseases or decreased functional capacity in primary care. The main hypothesis is that intervention has a positive impact on functional capacity and for rational and safe use of medicines.
- Detailed Description
Aging increases the risk of adverse effects and interactions caused by medication. Medication reconciliation and medication review are well-known practices to optimize medicines use. Both interventions usually require a team-based approach to be effective. Medication reconciliation is the process of obtaining and documenting a complete and accurate list of current patient medications and comparing this list with medication orders at each point of care transition to identify and rectify any discrepancies before patient harm occurs. Medication review is the process of evaluating current medication treatment to manage the risk and optimize the outcomes of medication treatment by detecting, solving, and preventing medication-related problems. The present study focuses on medication assessment including both medication reconciliation and review combined to clinical assessment of an individual patient.
According to a systematic review there is a need for research focusing on medication management in community settings and especially to assess the impact of medication assessment on clinical outcomes.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 514
Home dwelling ≥65 years-old persons registered to public home care services and who
- have had dizziness, orthostatic hypotension or have fallen or
- use at least six medicines
Home care is not responsible for patient's medication, for example due to severe chronic illness (for example severe renal insufficiency or cancer with active treatment in secondary or tertiary care).
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Functional capacity IADL (Instrumental Activities of Daily Living) at 6 months from baseline Functional capacity ADL (Activities of daily living;KATZ) at 6 months from baseline Functional capacity MMSE ( Mini-mental state examination) at 6 months from baseline Functional capacity TUG (Timed up and go) at 6 months from baseline Functional capacity GDS (Geriatric Depression Scale)-15 at 6 months from baseline
- Secondary Outcome Measures
Name Time Method Use of health care services at 6 and 12 months from baseline visits to physician, hospital days and nursing care at home
Quality of medicines at 6 and 12 months from baseline Health related quality of life assessed with EQ-5D at 6 and 12 months from baseline Cost of medicines at 6 and 12 months from baseline Need of services delivered to home at 6 and 12 months from baseline Number of medicines at 6 and 12 months from baseline
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (5)
Welfare district of Forssa
🇫🇮Forssa, Finland
Selänne Basic Health Care District
🇫🇮Haapajärvi, Finland
Juva Health Care
🇫🇮Juva, Finland
City of Lahti, home care
🇫🇮Lahti, Finland
Eastern Savo Hospital District
🇫🇮Savonlinna, Finland
Welfare district of Forssa🇫🇮Forssa, Finland